Relapsing-remitting multiple sclerosis (RRMS) is a form of multiple sclerosis characterized by unpredictable attacks (relapses) during which new symptoms appear or existing symptoms become more severe. These relapses are followed by periods of partial or complete recovery (remissions).
Understanding Relapsing-Remitting Multiple Sclerosis (RRMS)
RRMS is the most common form of MS, affecting approximately 85% of people with the disease when they are initially diagnosed. The course of RRMS is variable from person to person, and not everyone experiences the same symptoms or the same frequency of relapses.
Key Characteristics of RRMS:
-
Relapses (Attacks, Exacerbations): These are periods of neurological dysfunction that can last for days, weeks, or even months. Symptoms can vary widely depending on which areas of the central nervous system (brain, spinal cord, and optic nerves) are affected. Common symptoms include:
- Vision problems (e.g., optic neuritis, double vision)
- Muscle weakness
- Balance and coordination problems
- Numbness or tingling
- Fatigue
- Cognitive difficulties
-
Remissions: These are periods of recovery after a relapse. During remission, symptoms may improve partially or completely. Some individuals experience no residual symptoms, while others may have some lingering neurological deficits. The duration of remissions can also vary greatly.
Diagnosis of RRMS:
Diagnosis of RRMS typically involves:
- Neurological Examination: A doctor will assess your neurological function, including vision, strength, coordination, sensation, and reflexes.
- MRI Scans: Magnetic resonance imaging (MRI) can reveal lesions (areas of damage) in the brain and spinal cord, which are characteristic of MS.
- Spinal Tap (Lumbar Puncture): Analysis of cerebrospinal fluid (CSF) can help rule out other conditions and look for markers suggestive of MS.
- Evoked Potential Studies: These tests measure the electrical activity of the brain in response to stimulation, which can help detect damage to the optic nerve, brainstem, or spinal cord.
Treatment of RRMS:
The goals of treatment for RRMS are to:
- Reduce the frequency and severity of relapses. Disease-modifying therapies (DMTs) are medications that can help slow the progression of MS and reduce the number of relapses. Examples include injectable medications (e.g., interferon beta, glatiramer acetate), oral medications (e.g., dimethyl fumarate, fingolimod, teriflunomide), and infusions (e.g., natalizumab, ocrelizumab).
- Manage symptoms. Medications and other therapies can help relieve symptoms such as fatigue, pain, spasticity, and bladder problems.
- Improve quality of life. Rehabilitation therapies (e.g., physical therapy, occupational therapy, speech therapy) can help people with MS maintain their independence and improve their function.
Progression of RRMS:
Over time, RRMS can sometimes transition into a secondary progressive form of MS (SPMS), where there is a gradual worsening of neurological function, independent of relapses. However, with early diagnosis and effective treatment, many people with RRMS can maintain a good quality of life for many years.
In summary, Relapsing-Remitting Multiple Sclerosis is a specific type of MS involving periods of symptom exacerbation followed by periods of recovery, and it is essential to understand its characteristics for proper diagnosis and management.
